share_log

Avantor Participates in BioProcess International 2024 Conference Scientific Program and Exhibition

Avantor Participates in BioProcess International 2024 Conference Scientific Program and Exhibition

avantor参加2024年生物过程国际会议的科学项目和展览
PR Newswire ·  09/23 08:05

RADNOR, Pa., Sept. 23, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced the Company will deliver multiple scientific presentations and exhibit at BioProcess International 2024, scheduled for September 23-26 in Boston. Over 3,200 biopharmaceutical development and production professionals representing 40-plus countries are expected to attend.

宾夕法尼亚州雷德诺,2024年9月23日/美通社/--全球领先的生命科学和先进科技行业关键任务产品和服务提供商Avantor,Inc.(纽约证券交易所: AVTR)宣布公司将在波士顿举办的BioProcess International 2024上发表多个科学演讲并展示。预计将有来自40多个国家的3200多名生物制药开发和生产专业人士参加此次会议,会议定于9月23日至26日举行。

Avantor's scientific presentations at BioProcess International 2024 include:

Avantor在BioProcess International 2024年的科学演讲包括:

Presenter - Jungmin Oh, Ph.D., Senior Manager, New Product Development
Session Title - A novel approach to optimization of AAV harvest and purification process
Date and Time - September 25, 12:30 pm

演讲者-博士Jungmin Oh,新产品开发高级经理
会议主题-一种优化AAV收获和纯化过程的新方法
日期和时间-9月25日,下午12:30

Presenter - Nandu Deorkar, Ph.D., Senior Vice President, Biopharma Production Research & Development
Session Title - Keynote Address: Adapting to Changing Molecules and Regulatory Expectations
Date and Time – September 26, 10:00 am

演讲者-博士Nandu Deorkar,生物制药生产研发高级副总裁
会议主题-主题演讲:适应变化中的分子和监管期望
日期和时间-9月26日,上午10:00

Presenter - Jerry Keybl, Ph.D., Senior Vice President, Biopharma Products & Strategy
Session Title - Viral Gene Therapy Manufacturing at Scale – Assembling Solutions to Drive Industrialization
Date and Time - September 26, 12:15 pm

演讲者-杰瑞·凯布尔博士,生物制药产品与战略高级副总裁
会议主题-规模下的病毒基因疗法制造-组装解决方案推动产业化
日期和时间-9月26日,下午12:15

"Avantor's significant presence at BioProcess International 2024 is a testament to our reputation for delivering leading solutions across the spectrum of biopharmaceutical development and production," said Benoit Gourdier, Executive Vice President and Head of Avantor's Bioscience Production Segment. "We look forward to engaging with customers and attendees in Boston and showcasing how our innovative solutions can help solve their most demanding production challenges."

“Avantor在BioProcess International 2024展现的重要存在证明了我们在生物制药发展和生产领域提供领先解决方案的声誉,”该公司生命科学生产部门执行副总裁兼头崗负责人贝努瓦·固尔迪耶表示。“我们期待与波士顿的客户和与会者互动,展示我们的创新解决方案如何帮助解决其最严峻的生产挑战。”

In addition to its multiple scientific presentations, Avantor will also have a strong presence on the exhibit floor, focusing on its industry leading solutions for production scale up and downstream process optimization. Avantor will present its Magnetic Mixing Systems portfolio, which ranges from 50 to 1500 liters, and now includes a newly launched tabletop mixer for single-use mixing needs. These scalable Magnetic Mixing Systems are designed to maximize mixing efficiency with low shear rates, ensuring consistent homogeneity and minimizing risk to product quality. Avantor's experienced team of engineers can also help design specialized solutions tailored to customers unique bioprocessing mixing needs.

除了多个科学演示外,Avantor还将在展位上展示强大存在,重点放在其行业领先的生产规模扩大和下游工艺优化解决方案上。Avantor将展示其磁性搅拌系统产品组合,涵盖从50到1500升的范围,现在还包括新推出的用于一次性混合需求的桌面混合器。这些可扩展的磁性搅拌系统旨在通过低剪切速率来最大化混合效率,确保一致均匀性,并将产品质量风险降至最低。Avantor经验丰富的工程团队还可以帮助设计专门针对客户独特生物加工混合需求的解决方案。

About Avantor
Avantor is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.

关于 avantor,它是一家领先的生命科学工具公司,向生命科学和先进科技行业的客户提供关键产品和服务。我们在整个科研过程中与客户并肩工作,促进医学、医疗保健和技术的突破。我们的产品组合在几乎每个最重要的研究、开发和生产活动的各个阶段都被应用,在180个国家的300,000多个客户位置使用。有关更多信息,请访问 avantorsciences.com 并在 LinkedIn,X(Twitter)和 Facebook 上找到我们。
avantor是一家领先的生命科学工具公司,也是生命科学和爱文思控股行业中全球货币的关键产品和服务供应商。我们与客户并肩合作,助力科学探索的每一步,实现医药、保健和科技方面的突破。我们的产品组合在超过180个国家的30万多个客户地点中的几乎每个重要研究、开发和生产活动阶段都得到应用。欲获取更多信息,请访问avantorsciences.com,或在LinkedIn、X(Twitter)和Facebook上关注我们。

Global Media Contact
Eric Van Zanten
Head of External Communications
Avantor
610-529-6219
[email protected]

全球媒体联系人
Eric Van Zanten
外部通信负责人Lina Danstrup;电话:+45 30 77 05 52;anse@novozymes.com。
Avantor
610-529-6219
[email protected]

Investor Relations Contact
Christina Jones
Vice President, Investor Relations
Avantor
805-617-5297
[email protected]

投资者关系联系人
Christina Jones
投资者关系副总裁
Avantor
805-617-5297
[email protected]

SOURCE Avantor and Financial News

资料来源:Avantor和Financial News

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

想要您公司的新闻在PRNEWSWIRE.COM上特色呈现吗?

440k+
440k+

Newsrooms &
新闻发布室&

Influencers
影响力
9k+
9k+

Digital Media
数字媒体

Outlets
卖场
270k+
270k+

Journalists
新闻记者

Opted In
已选择加入
GET STARTED
开始使用
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发